Neogen Corporation Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Neogen Corporation (NEOG) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $2.50 million as of 2024-02-29, per its 10-Q filed 2024-04-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2024-04-09
- 2024-02-29: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $2.50M.
- 2023-11-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $2.57M.
- 2023-08-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $2.64M.
- 2023-05-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2024-02-29 | $2.50M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $2.57M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $2.64M 10-Q · filed 2023-10-10 |
| 2023-05-31 | $0.00 10-Q · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |